Kromek makes headlines as work forges on with the Low Dose MBI Program.


Pioneering work being championed here in the Northeast by Kromek, Newcastle-upon-Tyne Hospitals NHS Foundation Trust (“Newcastle Hospitals”), the University of Newcastle-upon-Tyne and University College London, made TV headlines this week after a further £2.5m of funding was awarded from the UK’s innovation agency, Innovate UK.

Featuring on BBC Look North, we reiterated the importance of the continued work that forges on with the Low Dose MBI Program. On Thursday 2nd February 2023, Dr Nerys Forester, Consultant Breast Radiologist at Newcastle Hospitals highlighted the importance of better, quicker, and less obtrusive breast cancer detection for women with dense breast tissue.

Current Mammography technology is often less able to clearly image tumours due to the density of the breast tissue, resulting in longer diagnosis times. Low-dose molecular breast imaging uses a radioactive tracer, developed by the team at Kromek with our partners, that ‘lights up’ areas of cancer in the breast and is effective even in dense breast tissue – which is prevalent in people who are at higher risk of cancer, ultimately offering the capacity to save thousands more lives, detecting cancers earlier, before they have time to spread.

As part of the two funding streams, leaders in the field of cancer detection will be able to further prove the feasibility of the low dose MBI program through clinical trails and data.

See the full interview here:

  Back to Latest

Related articles